Response to Comparison of Urine to Oral Fluid and the Recommendation for Routine Drug Analysis for Driving Under the Influence Cases
Barry K. Logan1,2,Amanda L. (Arntson) Mohr1 and Stephen K. Talpins3
1The Center for Forensic Science Research and Education, Willow Grove, PA 19090, USA, 2NMS Labs, Willow Grove, PA, USA, and 3Institute for Behavior and Health Inc., Rockville, MD, USA
The article Response to Comparison of Urine to Oral Fluid and the Recommendation for Routine Drug Analysis for Driving Under the Influence Cases appears in the Journal of Analytical Toxicology (doi:10.1093/jat/bkv009). Abstract is included below.
Please e-mail us if you would like a PDF copy of the published article.
ABSTRACT: We have reviewed the critique by Tiscione of our report evaluating the use of field based oral fluid drug testing in suspected impaired drivers in Miami. Based on our understanding of the author’s concerns we offer the following rebuttal. Tiscione asks: Is the scope of testing in our study design representative of a ‘real world comparison’ between oral fluid and urine drug testing and does it demonstrate that oral fluid testing is superior to urine drug testing? We are comparing a proposed solution, oral fluid drug testing, using two commercially available platforms with the at-that-time urine drug testing procedure used in Miami Dade County at the University of Miami, Toxicology Laboratory. Based on that comparison, higher rates of drug positives for the most frequently encountered impairing drugs were obtained by testing oral fluid samples rather than urine. No doubt the urine drug testing procedures could be improved to detect more drugs or to have greater sensitivity, and produce a more favorable comparison with oral fluid; however based on current practice, our data support a preference for oral fluid for the drugs targeted in the scope of the Dräger Drug Test 5000 and DrugWipe devices. While the oral fluid test is targeted to the most prevalent impairing drugs in driving under the influence (DUI) cases, it is not comprehensive, and the urine tests using gas chromatography–mass spectrometry (GC–MS) do have a broader scope than the scope of either field based oral fluid device. Subjects’ urine tested positive for the following drugs, which were outside the scope of the oral fluid test: phenylpropanolamine levamisole, quetiapine, promethazine, citalopram, sertraline, paroxetine, chlorpheniramine, diphenhydramine, doxylamine, dextromethorphan, methylone and tramadol. Collecting oral fluid samples is faster and easier than collecting urine samples however, and the officers participating in the study expressed a preference for collecting oral fluid samples over urine.
NMS Labs is the only independent forensic facility in the nation to be certified by both the ABFT (American Board of Forensic Toxicology) and ANAB-ASCLD/LAB-International (ANSI/ASQ National Accreditation Board-American Society of Crime Lab Directors/Lab Accreditation Board ISO 17025). ISO 17025 accreditation covers the disciplines of Toxicology, DNA, serology and controlled substances. We diligently maintain and exceed the high standards set by these organizations, so that you can have the utmost confidence in your testing results.